These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 8184217)
1. [How I treat... a non-obese patient with Type 2 diabetes]. Scheen AJ Rev Med Liege; 1994 Mar; 49(3):121-2. PubMed ID: 8184217 [No Abstract] [Full Text] [Related]
2. Biguanides enhance glucose utilization and insulin action in peripheral tissues: an old finding from the sixties of the last century. Schatz H Horm Metab Res; 2006 Oct; 38(10):690. PubMed ID: 17075781 [No Abstract] [Full Text] [Related]
3. [Oral and dietary treatments of type 2 diabetes]. Godeau T; Charbonnel B Rev Prat; 1992 May; 42(9):1093-8. PubMed ID: 1496236 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacologic treatment of diabetes]. De Montigny P; Clerc C; Descarpentries C Perspect Infirm; 2006; 4(2):30-4. PubMed ID: 17184094 [No Abstract] [Full Text] [Related]
5. Treating type 2 diabetes: targeting the many causative factors. Sutherland JE; Hoehns JD J Fam Pract; 2004 May; 53(5):376-88. PubMed ID: 15125823 [No Abstract] [Full Text] [Related]
6. [Possibilities and limits of oral diabetes therapy]. Bruneder H Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376 [No Abstract] [Full Text] [Related]
7. Drugs for type 2 diabetes. Treat Guidel Med Lett; 2008 Jul; 6(71):47-54. PubMed ID: 18583949 [No Abstract] [Full Text] [Related]
8. Oral hypoglycemic agents in type II diabetes mellitus. Lubbos H; Miller JL; Rose LI Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707 [TBL] [Abstract][Full Text] [Related]
9. [Therapeutic utility of biguanides in the treatment of NIDDM]. Fujimoto S Nihon Rinsho; 1999 Mar; 57(3):657-62. PubMed ID: 10199150 [TBL] [Abstract][Full Text] [Related]
11. [Biguanides in oral antidiabetic therapy: indications and limitations]. Gregorio F; Filipponi P Medicina (Firenze); 1988; 8(3):262-8. PubMed ID: 3231038 [No Abstract] [Full Text] [Related]
12. Transient type 2 diabetes mellitus in a raccoon (Procyon lotor). McCain S; Kirk C; Ramsay E J Zoo Wildl Med; 2008 Dec; 39(4):622-5. PubMed ID: 19110706 [TBL] [Abstract][Full Text] [Related]
13. [Oral therapy of type II diabetes]. Haupt E; Schöffling K Med Klin (Munich); 1989 Apr; 84(4):203-7. PubMed ID: 2657363 [No Abstract] [Full Text] [Related]
14. [Knack of treatment with oral hypoglycemic drugs in the elderly]. Komatsu M; Hashizume K Nihon Rinsho; 2006 Jan; 64(1):93-8. PubMed ID: 16408454 [TBL] [Abstract][Full Text] [Related]
15. [Spectrum of erythrocyte membrane lipids in various types of hypoglycemic therapy]. Kozlov GS; Buĭdina TA; Balabolkin MI Sov Med; 1990; (6):10-3. PubMed ID: 2396109 [TBL] [Abstract][Full Text] [Related]
16. [Type 1 diabetes mellitus: pathogenesis, symptoms and therapy]. Gero L Orv Hetil; 2010 Mar; 151(13):533-9. PubMed ID: 20304746 [TBL] [Abstract][Full Text] [Related]
19. The use of insulin in cystic fibrosis-related diabetes: a philosophical difference from the use of insulin in type 1 and type 2 diabetes. Bremer AA Pediatr Pulmonol; 2012 Nov; 47(11):1039-41. PubMed ID: 22911489 [No Abstract] [Full Text] [Related]